Distinct differences in platelet production and function between neonates and adults: Implications for platelet transfusion practice

Transfusion

Volumn 53, Issue 11, 2013, Pages 2814-2821

  Ferrer Marin, Francisca ^b   Stanworth, Simon ^b   Josephson, Cassandra ^b   Sola Visner, Martha ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; AMPICILLIN; ANTIBIOTIC AGENT; COLLAGEN; GLYCOPROTEIN IB ALPHA; IBUPROFEN; INDOMETACIN; MAMMALIAN TARGET OF RAPAMYCIN; SOMATOMEDIN; THROMBIN; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; VON WILLEBRAND FACTOR;

ADULT; AGGREGOMETRY; ANTIBIOTIC THERAPY; ANTIGEN EXPRESSION; BLOOD SAFETY; BRAIN HEMORRHAGE; CALCIUM MOBILIZATION; CELL MATURATION; CLINICAL DECISION MAKING; CLINICAL OBSERVATION; CYTOPLASM; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HEMOSTASIS; HOSPITALIZATION; HUMAN; IMMUNE FUNCTION TEST; IN VITRO STUDY; INCIDENCE; LIVER DYSFUNCTION; MATERNAL HYPERTENSION; MEDICAL PRACTICE; MEGAKARYOCYTE; MEGAKARYOPOIESIS; NECROTIZING ENTEROCOLITIS; NEONATAL HEMORRHAGE; NEONATAL THROMBOCYTOPENIA; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; NONHUMAN; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; PEDIATRIC HOSPITAL; POLYPLOIDY; PREGNANCY DIABETES MELLITUS; PREMATURITY; PREVALENCE; PROTEIN PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SEPSIS; SIGNAL TRANSDUCTION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; UMBILICAL CORD BLOOD;

ADULT; BLOOD PLATELETS; HEMOSTASIS; HUMANS; INFANT, NEWBORN; PLATELET TRANSFUSION; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE; THROMBOPOIESIS;

EID: 84887820803     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12343     Document Type: Review

References (53)

1. Wiedmeier SE, Henry E, Sola-Visner MC, Christensen RD,. Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system. J Perinatol 2009; 29: 130-136.
2. Olson TA, Levine RF, Mazur EM, Wright DG, Salvado AJ,. Megakaryocytes and megakaryocyte progenitors in human cord blood. Am J Pediatr Hematol Oncol 1992; 14: 241-247.
3. Liu ZJ, Italiano J Jr, Ferrer-Marin F, Gutti R, Bailey M, Poterjoy B, Rimsza L, Sola-Visner M,. Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes. Blood 2011; 117: 4106-4117.
4. Ma DC, Sun YH, Chang KZ, Zuo W,. Developmental change of megakaryocyte maturation and DNA ploidy in human fetus. Eur J Haematol 1996; 57: 121-127.
5. Huang Z, Richmond TD, Muntean AG, Barber DL, Weiss MJ, Crispino JD,. STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice. J Clin Invest 2007; 117: 3890-3899.
6. Klusmann JH, Godinho FJ, Heitmann K, Maroz A, Koch ML, Reinhardt D, Orkin SH, Li Z,. Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis. Genes Dev 2010; 24: 1659-1672.
7. Harker LA, Finch CA,. Thrombokinetics in man. J Clin Invest 1969; 48: 963-974.
8. Sola-Visner MC, Christensen RD, Hutson AD, Rimsza LM,. Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates. Pediatr Res 2007; 61: 479-484.
9. Hu Z, Slayton WB, Rimsza LM, Bailey M, Sallmon H, Sola-Visner MC,. Differences between newborn and adult mice in their response to immune thrombocytopenia. Neonatology 2010; 98: 100-108.
10. Sitaru AG, Holzhauer S, Speer CP, Singer D, Obergfell A, Walter U, Grossmann R,. Neonatal platelets from cord blood and peripheral blood. Platelets 2005; 16: 203-210.
11. Corby DG, O'Barr TP,. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine. Dev Pharmacol Ther 1981; 2: 215-225.
12. Gelman B, Setty BN, Chen D, Amin-Hanjani S, Stuart MJ,. Impaired mobilization of intracellular calcium in neonatal platelets. Pediatr Res 1996; 39: 692-696.
13. Israels SJ, Odaibo FS, Robertson C, McMillan EM, McNicol A,. Deficient thromboxane synthesis and response in platelets from premature infants. Pediatr Res 1997; 41: 218-223.
14. Andrew M, Paes B, Johnston M,. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990; 12: 95-104.
15. Israels SJ, Cheang T, McMillan-Ward EM, Cheang M,. Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. J Pediatr 2001; 138: 116-119.
16. Andrew M, Paes B, Bowker J, Vegh P,. Evaluation of an automated bleeding time device in the newborn. Am J Hematol 1990; 35: 275-277.
17. Shenkman B, Linder N, Savion N, Tamarin I, Dardik R, Kennet G, German B, Varon D,. Increased neonatal platelet deposition on subendothelium under flow conditions: the role of plasma von Willebrand factor. Pediatr Res 1999; 45: 270-275.
18. Straub A, Smolich J, d'Udekem Y, Brizard C, Peter K, Horton S,. Activation of platelets in young infants during cardiopulmonary bypass. Thromb Haemost 2010; 103: 466-469.
19. Ichinose F, Uezono S, Muto R, Uchida H, Hatori F, Terui K, Niimi Y, Goto T, Nakata Y, Morita S,. Platelet hyporeactivity in young infants during cardiopulmonary bypass. Anesth Analg 1999; 88: 258-262.
20. Bednarek FJ, Bean S, Barnard MR, Frelinger AL, Michelson AD,. The platelet hyporeactivity of extremely low birth weight neonates is age-dependent. Thromb Res 2009; 124: 42-45.
21. Ucar T, Gurman C, Arsan S, Kemahli S,. Platelet aggregation in term and preterm newborns. Pediatr Hematol Oncol 2005; 22: 139-145.
22. Linder N, Shenkman B, Levin E, Sirota L, Vishne TH, Tamarin I, Dardik R, Lubin D, Savion N, Varon D,. Deposition of whole blood platelets on extracellular matrix under flow conditions in preterm infants. Arch Dis Child Fetal Neonatal Ed 2002; 86: F127-130.
23. Del Vecchio A, Latini G, Henry E, Christensen RD,. Template bleeding times of 240 neonates born at 24 to 41 weeks gestation. J Perinatol 2008; 28: 427-431.
24. Saxonhouse MA, Garner R, Mammel L, Li Q, Muller KE, Greywoode J, Miller C, Sola-Visner M,. Closure times measured by the platelet function analyzer PFA-100 are longer in neonatal blood compared to cord blood samples. Neonatology 2010; 97: 242-249.
25. Hezard N, Potron G, Schlegel N, Amory C, Leroux B, Nguyen P,. Unexpected persistence of platelet hyporeactivity beyond the neonatal period: a flow cytometric study in neonates, infants and older children. Thromb Haemost 2003; 90: 116-123.
26. Sola-Visner M,. Platelets in the neonatal period: developmental differences in platelet production, function, and hemostasis and the potential impact of therapies. Hematology Am Soc Hematol Educ Program 2012; 2012: 506-511.
27. Burrows RF, Kelton JG,. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am J Obstet Gynecol 1990; 162: 731-734.
28. Christensen RD, Henry E, Wiedmeier SE, Stoddard RA, Sola-Visner MC, Lambert DK, Kiehn TI, Ainsworth S,. Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system. J Perinatol 2006; 26: 348-353.
29. Chakravorty S, Roberts I,. How I manage neonatal thrombocytopenia. Br J Haematol 2012; 156: 155-162.
30. Sola-Visner M, Saxonhouse MA, Brown RE,. Neonatal thrombocytopenia: what we do and don't know. Early Hum Dev 2008; 84: 499-506.
31. Goerge T, Ho-Tin-Noe B, Carbo C, Benarafa C, Remold-O'Donnell E, Zhao BQ, Cifuni SM, Wagner DD,. Inflammation induces hemorrhage in thrombocytopenia. Blood 2008; 111: 4958-4964.
32. Bussel JB, Sola-Visner M,. Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia. Semin Perinatol 2009; 33: 35-42.
33. Stanworth SJ,. Thrombocytopenia, bleeding, and use of platelet transfusions in sick neonates. Hematology Am Soc Hematol Educ Program 2012; 2012: 512-516.
34. Andrew M, Castle V, Saigal S, Carter C, Kelton JG,. Clinical impact of neonatal thrombocytopenia. J Pediatr 1987; 110: 457-464.
35. Stanworth SJ, Clarke P, Watts T, Ballard S, Choo L, Morris T, Murphy MF, Roberts I,. Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics 2009; 124: e826-834.
36. Muthukumar P, Venkatesh V, Curley A, Kahan BC, Choo L, Ballard S, Clarke P, Watts T, Roberts I, Stanworth S,. Severe thrombocytopenia and patterns of bleeding in neonates: results from a prospective observational study and implications for use of platelet transfusions. Transfus Med 2012; 22: 338-343.
37. von Lindern JS, van den Bruele T, Lopriore E, Walther FJ,. thrombocytopenia in neonates and the risk of intraventricular hemorrhage: a retrospective cohort study. BMC Pediatr 2011; 11: 16.
38. Baer VL, Lambert DK, Henry E, Christensen RD,. Severe Thrombocytopenia in the NICU. Pediatrics 2009; 124: e1095-1100.
39. Slichter SJ,. Evidence-based platelet transfusion guidelines. Hematology Am Soc Hematol Educ Program 2007; 172-178.
40. Josephson CD, Granger S, Assmann SF, Castillejo MI, Strauss RG, Slichter SJ, Steiner ME, Journeycake JM, Thornburg CD, Bussel J, Grabowski EF, Neufeld EJ, Savage W, Sloan SR,. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia. Blood 2012; 120: 748-760.
41. Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, Konkle BA, Woodson RD, Ortel TL, Hillyer CD, Skerrett DL, McCrae KR, Sloan SR, Uhl L, George JN, Aquino VM, Manno CS, McFarland JG, Hess JR, Leissinger C, Granger S,. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010; 362: 600-613.
42. New HV, Stanworth SJ, Engelfriet CP, Reesink HW, McQuilten ZK, Savoia HF, Wood EM, Olyntho S, Trigo F, Wendel S, Lin Y, Hume H, Petaja J, Krusius T, Villa S, Ghirardello S, von Lindern J, Brand A, Hendrickson JE, Josephson CD, Strauss RG, Luban NL, Paul W,. Neonatal transfusions. Vox Sang 2009; 96: 62-85.
43. Josephson CD, Castillejo MI, Caliendo AM, Waller EK, Zimring J, Easley KA, Kutner M, Hillyer CD, Roback JD,. Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (
44. Dohner ML, Wiedmeier SE, Stoddard RA, Null D Jr, Lambert DK, Burnett J, Baer VL, Hunt JC, Henry E, Christensen RD,. Very high users of platelet transfusions in the neonatal intensive care unit. Transfusion 2009; 49: 869-872.
45. Andrew M, Vegh P, Caco C, Kirpalani H, Jefferies A, Ohlsson A, Watts J, Saigal S, Milner R, Wang E,. A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993; 123: 285-291.
46. Estcourt LJ, Heddle N, Kaufman R, McCullough J, Murphy MF, Slichter S, Wood EM, Stanworth SJ,. The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions. Transfusion 2013; 53: 1531-1543.
47. Josephson CD, Su LL, Christensen RD, Hillyer CD, Castillejo MI, Emory MR, Lin Y, Hume H, Easley K, Poterjoy B, Sola-Visner M,. Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics 2009; 123: 278-285.
48. Chaudhary R, Clarke P,. Current transfusion practices for platelets and fresh, frozen plasma in UK tertiary level neonatal units. Acta Paediatr 2008; 97: 135.
49. Cremer M, Sola-Visner M, Roll S, Josephson CD, Yilmaz Z, Buhrer C, Dame C,. Platelet transfusions in neonates: practices in the United States vary significantly from those in Austria, Germany, and Switzerland. Transfusion 2011; 51: 2634-2641.
50. Stainsby D, Jones H, Wells AW, Gibson B, Cohen H,. Adverse outcomes of blood transfusion in children: analysis of UK reports to the serious hazards of transfusion scheme 1996-2005. Br J Haematol 2008; 141: 73-79.
51. Kenton AB, Hegemier S, Smith EO, O'Donovan DJ, Brandt ML, Cass DL, Helmrath MA, Washburn K, Weihe EK, Fernandes CJ,. Platelet transfusions in infants with necrotizing enterocolitis do not lower mortality but may increase morbidity. J Perinatol 2005; 25: 173-177.
52. Ferrer-Marin F, Chavda C, Lampa M, Michelson AD, Frelinger AL 3rd, Sola-Visner M,. Effects of in vitro adult platelet transfusions on neonatal hemostasis. J Thromb Haemost 2011; 9: 1020-1028.
53. Sallmon H, Gutti RK, Ferrer-Marin F, Liu ZJ, Sola-Visner MC,. Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care? J Perinatol 2010; 30: 765-769.